Investor Details
| Filer Name: | VERSANT VENTURE MANAGEMENT, LLC |
|---|---|
| CIK: | 1560009 |
| Period: | 2024-12-31 |
| Filed At: | 2025-02-11 |
| Number of Holdings: | 7 |
| Portfolio Value: | $0.09B |
Versant Venture Management, Llc Top Holdings
| Ticker | Exchange | Security | Shares | Value | % of Portfolio | Position Change | Put/Call |
|---|---|---|---|---|---|---|---|
| GLUE | US | MONTE ROSA THERAPEUTICS INC | 5,652,922 | $39M | 45.22% | 100.0% | - |
| CRSP | US | CRISPR THERAPEUTICS AG | 498,558 | $20M | 22.62% | - | - |
| CTNM | US | CONTINEUM THERAPEUTICS INC-A | 918,163 | $13M | 15.51% | - | - |
| SKYE | US | SKYE BIOSCIENCE INC | 2,007,704 | $6M | 6.55% | - | - |
| RPTX | US | REPARE THERAPEUTICS INC | 2,646,657 | $3M | 4.00% | - | - |
| TPST | US | TEMPEST THERAPEUTICS INC | 3,507,055 | $3M | 3.37% | 100.0% | - |
| ADVMUSD | EO | ADVERUM BIOTECHNOLOGIES INC | 506,821 | $2M | 2.73% | - | - |